Medicare & Medicaid Enrollees In Many High-Need Areas May Lack Access To Medications For Opioid Use Disorder

On September 18, 2022, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) published this report which found that Medicare and Medicaid enrollees in many high-need areas may lack access to medications for opioid use disorder (OUD). The goals of this analysis were to determine the extent to which provider organizations of medications for OUD (MOUD) were in areas of high need in 2022, determine the extent to which provider organizations prescribed or administered MOUD to Medicare and Medicaid enrollees in 2022, and identify factors that supported or impeded provider organizations' ability and . . .